Abstract |
This article is a review of "Long-term effects of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial" by Burn et al. (2011), Lancet, 378, 2081-2087. For another perspective on the Burn et al. article as well as a discussion of challenges faced when interpreting a large prospective trial, please see the related article by Rita Wickham.
|
Authors | Sarah Leilani Beck |
Journal | Journal of the advanced practitioner in oncology
(J Adv Pract Oncol)
Vol. 3
Issue 6
Pg. 395-8
(Nov 2012)
ISSN: 2150-0878 [Print] United States |
PMID | 25031971
(Publication Type: Journal Article, Review)
|